About Protein Dok-7
Protein Dok-7 (DOK7) is a protein
from Homo sapiens identified by UniProt accession
Q18PE1, 504 residues long.
MolForge cross-references it against 0 known binders and
121 disease associations.
Target properties
| Protein name | Protein Dok-7 |
| UniProt accession | Q18PE1 |
| Gene | DOK7 |
| Organism | Homo sapiens |
| Length | 504 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (121)
Diseases linked to this target (Open Targets).
- Congenital myasthenic syndromes · score 0.81
- Postsynaptic congenital myasthenic syndromes · score 0.72
- fetal akinesia deformation sequence · score 0.69
- fetal akinesia deformation sequence 1 · score 0.66
- congenital myasthenic syndrome · score 0.63
- genetic disorder · score 0.47
- vital capacity · score 0.45
- vitamin D measurement · score 0.44
- Abnormality of the musculature · score 0.41
- platelet count · score 0.40
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q18PE1-F1 | alphafold | PREDICTED | 64.31 | — |
Amino-acid sequence (504 residues)
MTEAALVEGQ VKLRDGKKWK SRWLVLRKPS PVADCLLMLV YKDKSERIKG LRERSSLTLE DICGLEPGLP YEGLVHTLAI VCLSQAIMLG FDSHEAMCAW DARIRYALGE VHRFHVTVAP GTKLESGPAT LHLCNDVLVL ARDIPPAVTG QWKLSDLRRY GAVPSGFIFE GGTRCGYWAG VFFLSSAEGE QISFLFDCIV RGISPTKGPF GLRPVLPDPS PPGPSTVEER VAQEALETLQ LEKRLSLLSH AGRPGSGGDD RSLSSSSSEA SHLDVSASSR LTAWPEQSSS SASTSQEGPR PAAAQAAGEA MVGASRPPPK PLRPRQLQEV GRQSSSDSGI ATGSHSSYSS SLSSYAGSSL DVWRATDELG SLLSLPAAGA PEPSLCTCLP GTVEYQVPTS LRAHYDTPRS LCLAPRDHSP PSQGSPGNSA ARDSGGQTSA GCPSGWLGTR RRGLVMEAPQ GSEATLPGPA PGEPWEAGGP HAGPPPAFFS ACPVCGGLKV NPPP
Explore Protein Dok-7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets